ClinicalTrials.Veeva

Menu

Safety Evaluation of Advantage Anti-Caries Varnish

A

Advantage Dental Services

Status and phase

Completed
Phase 1

Conditions

Dental Caries

Treatments

Drug: Varnish

Study type

Interventional

Funder types

Industry

Identifiers

NCT02645617
PVP-I Varnish

Details and patient eligibility

About

The purpose of the study is to confirm the safety of Advantage Anti-Caries Varnish.

Full description

This is an open-label Phase 1 study. The active ingredients are Povidone Iodine and Sodium Fluoride [Therametrics Technologies, Inc, Noblesville, IN, USA]. The oral soft tissues and teeth of the children will be examined and the test varnish to the teeth. The child will be re-examined at 24-48 hours for the presence of adverse oral soft tissue changes. At the follow-up, a qualified dental provider will ask questions focused on adverse events.

Enrollment

12 patients

Sex

All

Ages

36 to 60 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy

Exclusion criteria

  • Weight less than 15 kg or hypersensitivity to iodine

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Varnish
Experimental group
Description:
Dental varnish containing povidone iodine and sodium fluoride
Treatment:
Drug: Varnish

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems